Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy!

Acta Tropica

Volumn 95, Issue 3, 2005, Pages 305-315

  Mutabingwa, T K ^a,b,c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c C/o Muheza DDH ^*  (Tanzania)

Author keywords

Artemisinin based combination therapy; Control tools; Malaria; Resistance

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEKIN; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ARTESUNATE PLUS CHLORPROGUANIL PLUS DAPSONE; CHLORPROGUANIL PLUS DAPSONE; DIHYDROARTEMISININ PLUS PIPERAQUINE; FANSIDAR; MEFLOQUINE; UNCLASSIFIED DRUG;

DISEASE CONTROL; DRUG DEVELOPMENT; MALARIA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; ASIA; CLINICAL TRIAL; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; CYTOTOXICITY; DRUG APPROVAL; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENTIATION; DRUG QUALITY; DRUG STORAGE; DRUG SURVEILLANCE PROGRAM; DRUG USE; ENDEMIC DISEASE; FINANCIAL MANAGEMENT; GAMETOCYTE; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE FINANCING; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITAL BED CAPACITY; HUMAN; INTERNATIONAL COOPERATION; MALARIA; MALARIA CONTROL; MEDICAL ETHICS; MEDICAL RESEARCH; MONOTHERAPY; PARASITE TRANSMISSION; PARASITE VIRULENCE; PREGNANCY; PRIVATE PRACTICE; PUBLIC HEALTH SERVICE; SIDE EFFECT; TERATOGENICITY; THAILAND; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; HEALTH POLICY; HUMANS; MALARIA; POVERTY AREAS; RESEARCH DESIGN;

CHLOROCRAMBE HASTATA;

EID: 23944451082     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2005.06.009     Document Type: Article

References (43)

1. M. Adjuik, A. Babiker, P. Garner, P. Olliaro, W. Taylor, N. White International Artemisinin Study Group Artesunate combinations for treatment of malaria: meta-analysis Lancet 363 9402 2004 9 17
2. M.H. Alin, M. Ashton, C.M. Kihamia, G.J. Mtey, and A. Bjorkman Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria Br. J. Clin. Pharmacol. 41 1996 587 592
3. E.A. Ashley, S. Krudsood, L. Phaiphun, S. Srivilairit, R. McGready, W. Leowattana, R. Hutagalung, P. Wilairatana, A. Brockman, S. Looareesuwan, F. Nosten, and N.J. White Dose optimization randomised controlled studies of dihydroartemisinin-pipearquin for the treatment of uncomplicated multi-drug resistant falciparum malaria in Thailand J.I.D. 190 2004 1773 1778
4. A. Attaran, K.I. Barnes, C. Curtis, U. d'Alessandro, C.I. Fanello, M.R. Galinski, G. Kokwaro, S. Looareesuwan, M. Makanga, T.K. Mutabingwa, A. Talisuna, J.F. Trape, and W.M. Watkins WHO, the Global Fund, and medical malpractice in malaria treatment Lancet 363 2004 237 240
5. K.I. Barnes, and N.J. White Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum Acta Trop. 94 2005 230 240
6. P.B. Bloland, M. Ettling, and S. Meek Combination therapy for malaria in Africa: hype or hope? Bull. World Health Org. 78 12 2000 1378 1388
7. B.J. Brabin, T.A. Eggelte, M. Parise, and F. Verhoeff Dapsone therapy for malaria during pregnancy: maternal and foetal outcomes Drug Saf. 27 9 2004 633 648
8. Curtis, C.F., Maxwell, C.A., Magesa, S.M., Rwegoshora, R.T., Wilkes, T.J. Insecticide treated bednets, personal communication.
9. T.M. Davis, T.Y. Hung, I.K. Sim, H.A. Karunajeewa, and K.F. Ilett Piperaquine: a resurgent antimalarial drug Drugs 65 1 2005 75 87
10. M.B. Denis, T.M. Davis, S. Hewitt, S. Incardona, K. Nimol, T. Fandeur, Y. Poravuth, C. Lim, and D. Socheat Efficacy and safety of dihydroartemisinin- piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria Clin. Infect. Dis. 35 2002 1469 1476
11. E. Depoortere, J.P. Guthmann, N. Sipilanyame, E. Nkadu, F. Fermon, S. Balkan, and D. Legros Adherence to the combination of sulfadoxine-pyrimethamine and artesunate in the Maheba refugee settlement Zambia. Trop. Med. Int. Health. 9 1 2004 62 67
12. J.F. Doherty, A.D. Sadiq, L. Bayo, A. Alloueche, P. Olliaro, P. Milligan, L. von Seidlein, and M. Pinder A randomised safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children Trans. R. Soc. Trop. Med. Hyg. 93 5 1999 543 546
13. I.C. Gougna, H.M. Ferguson, B.A. Oket, G.F. Killeen, F.W. Kabiru, J.C. Beier, J.J. Githure, and G. Yan Plasmodium falciparum malaria disease manifestations in humans and transmission to Anopheles gambiae: a field study in Kenya Parasitology 128 2004 235 243
14. T.T. Hien, C. Dolecek, P.P. Mai, N.T. Dung, N.T. Truong, L.H. Thai, D.T.A. An, T.T. Thanh, K. Stepniewska, N. White, and J. Farrar Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial Lancet 363 2004 18 22
15. S.P. Kachur, R.A. Khatib, E. Kaizer, S.S. Fox, S.M. Abdulla, and P.B. Bloland Adherence to antimalarial combination therapy with sulfadoxine- pyrimethamine and artesunate in rural Tanzania Am. J. Trop. Med. Hyg. 71 6 2004 715 722
16. H. Karunajeewa, C. Lim, T.Y. Hung, K.F. Ilett, M.B. Denis, D. Socheat, and T.M.E. Davis Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodia children and adults with malaria Br. J. Clin. Phamacol. 57 2003 93 99
17. S. Looareesuwan Overview of clinical studies on artemisinin derivatives in Thailand Trans. R. Soc. Trop. Med. Hyg. 88 Suppl. 1 1994 S9 S11
18. H.M. McIntosh, and P. Olliaro Artemisinin derivatives for treating malaria Cochrane Database Syst. Rev. 2 2000 CD000256
19. F. Muheki, D. McIntyre, and K.I. Barnes Atemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa Trop. Med. Int. Health 9 2004 959 966
20. T.K. Mutabingwa, A. Devota, A. Heller, R. Hallet, J. Ahmed, C. Drakeley, B.M. Greenwood, and C.J.M. Whitty Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzania: a four-arm randomised effectiveness trial Lancet 365 2005 1474 1480
21. F. Nosten Artemisinis: large community studies Trans. R. Sco. Trop. Med. Hyg. 88 Suppl. 1 1994 S45 S46
22. F. Nosten, T.T. Hien, and N.J. White Use of artemisinin derivatives for the control of malaria Med. Trop. (Mars.) 58 Suppl. 3 1998 45 49
23. F. Nosten, M. van Vugt, R.N. Price, C. Luxemburger, K.L. Thway, A. Brockman, R. McGready, F. ter Kuile, S. Looareesuwan, and N.J. White Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study Lancet 356 2000 297 302
24. F. Nosten, and R. McGready The treatment of malaria in pregnancy P.E. Duffy M. Fried Malaria in Pregnancy: Deadly Parasite, Susceptible Host 2001 Taylor & Francis New York 223 240
25. C.O. Obonyo, F. Ochieng, W.R. Taylor, S. Ochola, K. Mugitu, P. Olliaro, F. ter Kuile, and A.J. Oloo Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomised, double blind, placebo-controlled trial Trans. R. Soc. Trop. Med. Hyg. 97 5 2003 589 591
26. P.A. Phillips-Howard, and D. Wood The safety of antimalarial drugs in pregnancy Drug Saf. 14 3 1996 131 145
27. S. Pincock Drug Company to offer new malaria drug cheaply in Africa Br. Med. J. 327 2003 360
28. R.N. Price, F. Nosten, C. Luxemburger, A. Kham, A. Brockman, T Chingsuphajaisiddhi, and N.J. White Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria Trans. R. Soc. Trop. Med. Hyg. 89 5 1995 523 527
29. R.N. Price, M. van Vugt, L. Phaipun, C. Luxemburger, J. Simpson, R. McGready, F. ter Kuile, A. Kham, T. Chingsuphajaisiddhi, N.J. White, and F. Nosten Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives Am. J. Trop. Med. Hyg. 60 4 1999 547 555
30. R.N. Price Artemisinin drugs: novel antimalarial agents Expert Opin. Investig. Drugs 9 8 2000 1815 1827
31. T. Shwe, M. Lwin, and S. Aung Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non-severe falciparum malaria in Myanmar Bull. World Health Org. 76 Suppl. 1 1998 35 41
32. C.J. Sutherland, R. Ord, S. Dunyo, J. Jawara, C.J. Drakeley, N. Alexander, R. Coleman, M. Pinder, G. Walraven, and G.A.T. Targett Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether PloS Med. 2 2005 e92
33. Tanzanian National Bureau of Statistics, 2001/01. Household Budget Survey, http://www.tanzania.go.tz/hbs/HomePage.
34. G. Target, C. Drakeley, M. Jawara, L. von Seidlein, R. Coleman, J. Deen, M. Pinder, T. Doherty, C. Sutherland, G. Walraven, and P. Milligan Artesunate reduces but does not prevent post treatment transmission of Plasmodium falciparum to Anopheles gambiae J. Infect. Dis. 183 8 2001 1254 1259
35. S. Toovey, and A. Jamieson Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether Trans. R. Soc. Trop. Med. Hyg. 98 5 2004 261 267
36. M. van Vugt, B.J. Anmgus, R.N. Price, C. Mann, J.A. Simpson, C. Poletto, S.E. Hto, S. Looareesuwan, N.J. White, and F. Nosten A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria Am. J. Trop. Med. Hyg. 62 1 2000 65 69
37. N.J. White, and P. Olliaro Artemisinin and derivatives in the treatment of uncomplicated malaria Med. Trop. (Mars.) 58 Suppl. 3 1998 54 56
38. N.J. White Antimalarial drug resistance and combination chemotherapy Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354 1999 739 749
39. N.J. White Delaying antimalarial drug resistance with combination chemotherapy Parasitologia 41 1999 301 308
40. C.J. Whitty, R. Allan, V. Wiseman, S. Ochola, M.V. Nakyanzi-Mugisha, B. Vonhom, M. Mwita, C. Miaka, A. Oloo, Z. Premji, C. Burgess, and T.K. Mutabingwa Averting a malaria disaster in Africa - where does the buck stop Bull. World Health Org. 82 5 2004 381 384
41. P. Wilairatana, S. Krudsood, K. Chalermut, C. Pengroska, S. Srivilairit, U. Silachamroon, S. Treeprasertsuk, and S. Looareesuwan An open randomized clinical trial of artecom vs. atesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand Southeast Asian J. Trop. Med. Public Health 33 3 2002 519 524
42. World Health Organization Antimalarial Drug Combination Therapy: Report of a Technical Consultation 2001 WHO Geneva
43. World Health Organization and United Nations Children Fund, 2005. World Malaria Report III. Global Financing and Service Delivery. http://rbm.who.int/ wmr2005/html/3-1/htm.